Drug Information

General Information
Drug ID
DR01473
Drug Name
Zoledronic acid
Synonyms
Aclasta; Reclast; ZOL; Zometa; Novartis brand of zoledronic acid; Zoledronic acid; Zometa Concentrate; Bisphosphonate 3; CGP 42446; CGP 42446A; Aclasta (TN); CGP 42'446; CGP-42446; KS-1132; Reclast (TN); Zoledronic acid (INN); Zoledronic acid [USAN:INN]; Zomera (TN); Zometa (Novartis); Zometa (TN); CGP-42'446; Zometa, Zomera, Aclasta and Reclast, Zoledronic Acid; [1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid); (1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid; (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid; (1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid; (1-hydroxy-2-imidazol-1-yl-phosphonoethyl)phosphonic acid monohydrate; 2-(imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic acid; 2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid
Drug Type
Small molecular drug
Indication Paget's disease [ICD11:FB85] Approved [1]
Therapeutic Class
Bone Density Conservation Agents
Structure
3D MOL 2D MOL
Formula
C5H10N2O7P2
Canonical SMILES
C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O
InChI
InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)
InChIKey
XRASPMIURGNCCH-UHFFFAOYSA-N
CAS Number
CAS 118072-93-8
Pharmaceutical Properties Molecular Weight 272.09 Topological Polar Surface Area 153
Heavy Atom Count 16 Rotatable Bond Count 4
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 8
XLogP
-4.3
PubChem CID
68740
PubChem SID
536160 ,6436371 ,7891233 ,7980916 ,8192311 ,10318362 ,10318375 ,10318390 ,10318944 ,11528905 ,14824151 ,25819963 ,29215499 ,29215500 ,43125267 ,46507310 ,46513035 ,50473172 ,53788750 ,53801236 ,56311814 ,56436259 ,56479320 ,57317038 ,81092860 ,85174457 ,87457600 ,89736141 ,92308965 ,92712542 ,93166450 ,93167152 ,96025372 ,99343600 ,99343604 ,99437087 ,99455519 ,103240897 ,104342928 ,109692939 ,117626547 ,118048654 ,124757161 ,125163965 ,125338822 ,126592903 ,126625470 ,126656631 ,126667014 ,127324075
ChEBI ID
ChEBI:46557
TTD Drug ID
D0VM2L
DT(s) Transporting This Drug MRP1 Transporter Info Multidrug resistance-associated protein 1 Substrate [2]
References
1 zoledronic acid was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study. Cell Biol Int. 2006 Mar;30(3):278-82.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.